ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för oxaliplatin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

30 träffar

Bibliografisk träff 2018-12-01

Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.

Fernandes GDS, Braghiroli MI, Artioli M, Paterlini ACCR, Teixeira MC, Gumz BP, Girardi DDM, Braghiroli OFM, Costa FP, Hoff PM.

J Gastrointest Cancer · journal article · DOI 10.1007/s12029-017-0001-3

Bibliografisk träff 2018-01-01

Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer.

Lan YQ, Wu RP, Huang XB, Wang XL, Zhong DT, Huang CY, Song JT.

Tumori · clinical trial; multicenter study; journal article · DOI 10.5301/tj.5000665

Bibliografisk träff 2018-01-01

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.

Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, Nadal C, Cavaletti G, Alberti P, Briani C, Kalofonos HP, Cortinovis D, Sust M, Vaqué A, Klein T, Plata-Salamán C.

Neurotherapeutics · clinical trial, phase ii; research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1007/s13311-017-0572-5

Bibliografisk träff 2017-12-01

Melatonin Attenuates Pain Hypersensitivity and Decreases Astrocyte-Mediated Spinal Neuroinflammation in a Rat Model of Oxaliplatin-Induced Pain.

Wang YS, Li YY, Cui W, Li LB, Zhang ZC, Tian BP, Zhang GS.

Inflammation · journal article · DOI 10.1007/s10753-017-0645-y

Bibliografisk träff 2017-10-06

Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice.

Feather CE, Lees JG, Makker PGS, Goldstein D, Kwok JB, Moalem-Taylor G, Polly P.

Muscle Nerve · research support, non-u.s. gov't; journal article · DOI 10.1002/mus.25966

Bibliografisk träff 2017-09-22

miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.

Jiang T, Ye L, Han Z, Liu Y, Yang Y, Peng Z, Fan J.

J Exp Clin Cancer Res · research-article; journal article · DOI 10.1186/s13046-017-0602-5

Bibliografisk träff 2017-09-08

Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.

Berenato R, Morano F, Pietrantonio F, Cotsoglou C, Caporale M, Infante G, Pellegrinelli A, Alessi A, Battiston C, Coppa J, Padovano B, Mennitto A, Niger M, Fucà G, Lazzati S, Greco G, Delconte G, de Braud F, Mazzaferro V, Di Bartolomeo M.

Oncology · clinical trial, phase ii; journal article · DOI 10.1159/000479154

Bibliografisk träff 2017-09-06

Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.

Iwai T, Yamada T, Koizumi M, Shinji S, Yokoyama Y, Takahashi G, Takeda K, Hara K, Ohta K, Uchida E.

J Surg Oncol · journal article · DOI 10.1002/jso.24756

Bibliografisk träff 2017-08-24

Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy.

Apostolidis L, Schwarz D, Xia A, Weiler M, Heckel A, Godel T, Heiland S, Schlemmer HP, Jäger D, Bendszus M, Bäumer P.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0183845

Bibliografisk träff 2017-08-12

CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients.

Yang L, Zou S, Shu C, Song Y, Sun YK, Zhang W, Zhou A, Yuan X, Yang Y, Hu S.

Genomics Proteomics Bioinformatics · letter · DOI 10.1016/j.gpb.2016.11.004

Bibliografisk träff 2017-08-11

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.

Siesing C, Sorbye H, Dragomir A, Pfeiffer P, Qvortrup C, Pontén F, Jirström K, Glimelius B, Eberhard J.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0182512

Bibliografisk träff 2017-08-01

Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.

Bréchon M, Dior M, Dréanic J, Brieau B, Guillaumot MA, Brezault C, Mir O, Goldwasser F, Coriat R.

Invest New Drugs · journal article · DOI 10.1007/s10637-017-0492-6

Bibliografisk träff 2017-07-19

First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study.

Satake H, Yasui H, Kotake T, Okita Y, Hatachi Y, Kotaka M, Kato T, Tsuji A.

Mol Clin Oncol · research-article; journal article · DOI 10.3892/mco.2017.1335

Bibliografisk träff 2017-07-10

Effect of ninjin'yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice.

Suzuki T, Yamamoto A, Ohsawa M, Motoo Y, Mizukami H, Makino T.

J Nat Med · journal article · DOI 10.1007/s11418-017-1113-6

Bibliografisk träff 2017-07-01

EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells.

Wen Q, Chen Z, Chen Z, Chen J, Wang R, Huang C, Yuan W.

Oncotarget · research-article; journal article · DOI 10.18632/oncotarget.18208

Bibliografisk träff 2017-07-01

Oxaliplatin reacts with DMSO only in the presence of water.

Varbanov HP, Ortiz D, Höfer D, Menin L, Galanski MS, Keppler BK, Dyson PJ.

Dalton Trans · brief-report; journal article · DOI 10.1039/c7dt01628j

Bibliografisk träff 2017-06-22

Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation.

Han CH, Khwaounjoo P, Hill AG, Miskelly GM, McKeage MJ.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-017-04383-4

Bibliografisk träff 2017-05-16

Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.

Waddle M, Irvin M, Gupta E, Gibbs M, Kakar TS, Gannon NA, Arthurs JR, Fischer DL, Ailawadhi S.

Chemotherapy · journal article; case reports · DOI 10.1159/000471844

Bibliografisk träff 2017-05-12

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.

De Felice F, Benevento I, Magnante AL, Musio D, Bulzonetti N, Caiazzo R, Tombolini V.

BMC Cancer · meta-analysis; research-article; journal article · DOI 10.1186/s12885-017-3323-4

Bibliografisk träff 2017-03-16

Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin.

Cui W, Fan W, Zhang Q, Wen J, Huang Y, Yang J, Li J, Wang Y.

Oncotarget · journal article · DOI 10.18632/oncotarget.16298

Bibliografisk träff 2017-03-01

[Cetuximab in association with an oxaliplatin-based chemotherapy as first-line treatment of metastatic colorectal cancer.]

Petrelli F, Ghidini A, Zaniboni A.

Recenti Prog Med · comparative study; review; journal article · DOI 10.1701/2656.27235

Tillbakadragen publikation 2017-02-10

Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?

Di Cesare Mannelli L, Pacini A, Micheli L, Femia AP, Maresca M, Zanardelli M, Vannacci A, Gallo E, Bilia AR, Caderni G, Firenzuoli F, Mugelli A, Ghelardini C.

Sci Rep · retracted publication; research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/srep42021

Bibliografisk träff 2016-10-15

Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.

Sánchez Cendra C, Juez Martel I, Gutierrez Abad D.

Arch Bronconeumol · journal article; case reports · DOI 10.1016/j.arbres.2016.08.010

Bibliografisk träff 2009-09-06

Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.

Chiu SJ, Lee YJ, Hsu TS, Chen WS.

Chem Biol Interact · research support, non-u.s. gov't; journal article · DOI 10.1016/j.cbi.2009.08.019

Bibliografisk träff 2009-01-12

Oxaliplatin neurotoxicity--no general ion channel surface-charge effect.

Broomand A, Jerremalm E, Yachnin J, Ehrsson H, Elinder F.

J Negat Results Biomed · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1477-5751-8-2

Bibliografisk träff 2008-04-25

Oxaliplatin doublets in non-small cell lung cancer: a literature review.

Cortinovis D, Bidoli P, Zilembo N, Fusi A, Bajetta E.

Lung Cancer · review; journal article · DOI 10.1016/j.lungcan.2008.03.005

Bibliografisk träff 2007-03-07

Synergistic antitumor activity of oxaliplatin in combination with gemcitabine in pancreatic tumor-bearing mice.

Moschidis A, Papageorgiou A, Atmatzidis K, Tsalis K, Moschidis E, Livanis J, Chrysogelou E, Mourelatos D, Tsavdaridis D, Harlaftis N.

Chemotherapy · journal article · DOI 10.1159/000100513

Bibliografisk träff 2004-01-01

FDA drug approval summaries: oxaliplatin.

Ibrahim A, Hirschfeld S, Cohen MH, Griebel DJ, Williams GA, Pazdur R.

Oncologist · clinical trial; multicenter study; randomized controlled trial; journal article · DOI 10.1634/theoncologist.9-1-8

Bibliografisk träff 2004-01-01

Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.

Gammon D, Bhargava P, McCormick MJ.

Oncologist · journal article; case reports · DOI 10.1634/theoncologist.9-5-546

Bibliografisk träff 2001-02-01

Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study.

Garufi C, Nisticò C, Brienza S, Vaccaro A, D'Ottavio A, Zappalà AR, Aschelter AM, Terzoli E.

Ann Oncol · clinical trial, phase ii; clinical trial; journal article · DOI 10.1023/a:1008386419047